NABP’s Executive Committee

As NABP’s governing body, the four officers and eight members who compose the Executive Committee volunteer their time and expertise to implement policy and oversee the Association’s programs and services. Officers and members are elected by the Association’s membership during the NABP Annual Meeting.

View the 2018-2019 Executive Committee

The 2019-2020 Executive Committee will be elected in May 2019 during the 115th Annual Meeting in Minneapolis, MN. Open officer positions include president-elect and treasurer. The open member positions are for Districts 1, 2, 3, and 5.

View the candidates for the 2019-2020 Executive Committee

Meet the 2018-2019 Executive Committee

Chairperson

Jeanne D. Waggener, RPh, DPh

Ms Waggener, former member of the Texas State Board of Pharmacy, is serving as chairperson of the Executive Committee. Prior to assuming office, she served one-year terms as president, president-elect, and treasurer, and one three-year term as an Executive Committee member representing District 6. An active member of NABP, Ms Waggener has participated in several task forces, including the Task Force on Sponsorship of NABP District and Annual Meetings, the Task Force on Prescription Drug Abuse, the Task Force on Internet Pharmacy Practice, and the Task Force to Review and Recommend Revisions to the Controlled Substances Act. She also served on the Committee on Constitution and Bylaws, as a panelist for the Tri-Regulator Symposiums in 2012 and 2015, and as Executive Committee liaison for the Advisory Committee on Examinations from 2012 to 2013. Ms Waggener is a pharmacy clinical services manager for Wal-Mart Health and Wellness and has worked in the community pharmacy environment for over 40 years. She earned a bachelor of science degree in pharmacy from the University of Texas at Austin and received an honorary doctor of pharmacy license from the Oklahoma State Board of Pharmacy.

President

Susan Ksiazek, RPh, DPh

Ms Ksiazek, a member of the New York State Board of Pharmacy, automatically assumed the office of president at NABP’s 114th Annual Meeting in May 2018. Prior to the election, she served one-year terms as president-elect and treasurer, and one three-year member term representing District 2 on the Executive Committee. An active member of NABP, Ms Ksiazek served as the District 2 secretary/treasurer for seven years. Ms Ksiazek participated in many of the Association’s task forces, including the Task Force on the Definition of a Patient-Pharmacist Relationship, the Task Force on Pharmacy Technician Education and Training Programs, the Task Force on Telepharmacy and the Implementation of the Medicare Drug Benefit Medication Therapy Management Provisions, and the Task Force to Examine NABP’s Data Resources. She also served on the Committee on Law Enforcement/Legislation and the hospital subgroup of the Task Force to Review and Recommend Revisions to the Controlled Substances Act. As a member of the New York State Board, Ms Ksiazek served two terms as chair.

Ms Ksiazek has diverse pharmacy experience including community, hospital, and long-term care practice with a clinical specialty in geriatrics. Ms Ksiazek’s expertise in medication safety and regulatory and accreditation compliance led her to a position in hospital administration as the director of medical staff quality and education at Erie County Medical Center in Buffalo, NY. Ms Ksiazek earned her bachelor of science degree in pharmacy from the State University of New York at Buffalo, School of Pharmacy and Pharmaceutical Sciences.

President-elect

Jack W. "Jay" Campbell IV, JD, RPh

Mr Campbell, executive director of the North Carolina Board of Pharmacy, is serving as president-elect. Prior to the election, he served a one-year term as treasurer and a three-year term as an Executive Committee member representing District 3. As an active member of NABP, Mr Campbell has made many contributions to the NABP District 3 meetings and previously served as president of District 3 from 2008 to 2017. In addition, he has served on many of the Association’s committees and task forces, including the Committee on Law Enforcement/Legislation, the Resolutions Committee, and the Task Force to Review and Recommend Revisions to the Controlled Substances Act. NABP awarded Mr Campbell the Lester E. Hosto Distinguished Service Award in 2013. He also teaches pharmacy law and ethics classes at three North Carolina universities. Mr Campbell earned his bachelor of science degree in pharmacy from the University of North Carolina at Chapel Hill and his juris doctor degree from Vanderbilt University School of Law.

Treasurer

Timothy D. Fensky, RPh, DPh, FACA

Mr Fensky, a member of the Massachusetts Board of Registration in Pharmacy, is serving as treasurer. Prior to the election, he served a two-year term as an Executive Committee member representing District 1. As a member of NABP, Mr Fensky has made many contributions to the NABP District 1 meetings and previously served as president of the Massachusetts Board of Registration in Pharmacy. Mr Fensky served on  the Task Force on Pharmacist Prescriptive Authority and as Executive Committee liaison for the Task Force on Best Practices for Veterinary Compounding. Mr Fensky is the pharmacy administrator at Bournewood Health Systems and the chief pharmacy officer at Sullivan’s Health Care. Further, he is recognized as a full fellow for the American College of Apothecaries and is an adjunct faculty member at Massachusetts College of Pharmacy and Health Sciences in Boston, MA. Mr Fensky earned his bachelor of science degree in pharmacy from Northeastern University, Bouvé College of Pharmacy and Health Sciences, and received an honorary doctor of pharmacy license from the Oklahoma State Board of Pharmacy.

Executive Committee Member

Bradley S. Hamilton, RPh

Mr Hamilton, vice president of the Maine Board of Pharmacy, is serving a one-year member term, representing District 1, on the Executive Committee. Mr Hamilton has made contributions to the NABP/AACP District 1 meetings. Mr Hamilton served on the Task Force on Expanding International Membership, represented the Maine Board as a voting delegate at the NABP Annual Meetings in 2016, 2017, and 2018, and participated in the 2015 Tri-Regulator Symposium. In 2014, Mr Hamilton was the recipient of the Retail Operations Honorary Backpack Award for his role at Hannaford Supermarket and Pharmacy. He was also named Distinguished Young Pharmacist of the Year in Maine by Pharmacists Mutual Insurance Company in 2006. Mr Hamilton earned his bachelor of science degree in pharmacy from Northeastern University, Bouvé College of Pharmacy and Health Sciences.

Executive Committee Member

Caroline D. Juran, RPh, DPh

Ms Juran, executive director of the Virginia Board of Pharmacy, is serving a three-year member term, representing District 2, on the Executive Committee. An active member of NABP, Ms Juran served as a member of the 2012 Task Force to Review and Recommend Revisions to the Controlled Substances Act, represented NABP on the 2012 Pharmacist Minimum Data Set Workgroup to develop questions for a universal pharmacy workforce survey, represented District 2 on the 2012 Resolutions Committee, served as a member of the Committee on Law Enforcement/Legislation from 2012-2015, where she served as chair from 2012-2013. She also participated on behalf of NABP at the 2015 Accreditation Council for Pharmacy Education stakeholders conference invitational and served as Executive Committee liaison for the 2016 Task Force on the Pharmacist Integrated Communications Skills Examination. Ms Juran also served as District 2 secretary/treasurer between 2013 and 2016. Under her leadership, the Virginia Board of Pharmacy received NABP’s Fred T. Mahaffey Award for contributions to the regulation of the practice of pharmacy and their efforts to ensure that compounding is performed in a safe and compliant manner. Ms Juran directly supported Virginia’s role in the initial phase and process development of the Verified Pharmacy Program (VPP) in 2013 and was appointed to the 2015-2016 Task Force on the Implementation of VPP. Ms Juran assisted in the development of the Multistate Pharmacy Inspection Blueprint Program and supported Virginia’s prompt participation as a Blueprint state. Ms Juran served in 2014 as an advisory committee member on the Pew Charitable Trust Development of Best Practices for State Oversight of Drug Compounding. She served as deputy executive director of the Virginia Board of Pharmacy from 2005-2010 and assumed the duties of executive director in 2010. Between 1995 and 2005, Ms Juran practiced as a community pharmacist and long-term care pharmacist. She held certification as a geriatric pharmacist and served as a pharmacy student preceptor. Ms Juran completed her studies at the College of William and Mary and earned her bachelor of science degree in pharmacy from Virginia Commonwealth University, Medical College of Virginia, and received an honorary doctor of pharmacy license from the Oklahoma State Board of Pharmacy.

Executive Committee Member

Reginald B. "Reggie" Dilliard, DPh

Mr Dilliard, executive director of the Tennessee Board of Pharmacy, is serving a three-year member term, representing District 3, on the Executive Committee. As a member of NABP, Mr Dilliard served on the Association’s task forces and committees, including the Task Force on the Regulation of Pharmacist Care Services, the Task Force to Develop Recommendations to Best Reduce Medication Errors in Community Pharmacy Practice, the Committee on Law Enforcement/Legislation, and the Committee on Constitution and Bylaws. He also served as Executive Committee liaison for the Advisory Committee on Examinations from 2017 to 2018. Prior to his current role on the Tennessee Board, Mr Dilliard worked as a pharmacy manager at Walgreens for almost 30 years. Mr Dilliard was also the pharmacist and manager of Super D Drugs for more than a decade. He is also an active member of other pharmacy organizations, including the Tennessee Pharmacists Association, where he served as president and chaired several committees. Mr Dilliard earned his bachelor of science degree in pharmacy from the University of Tennessee College of Pharmacy.

Executive Committee Member

Philip P. Burgess, MBA, DPh, RPh

Mr Burgess, a former member of the Illinois State Board of Pharmacy, is serving a second three-year member term, representing District 4, on the Executive Committee. An active member of NABP, Mr Burgess served on the Committee on Constitution and Bylaws, the Committee on Law Enforcement/Legislation, and the Task Force on Drug Return and Reuse Programs. He also was Executive Committee liaison for the Task Force on the Regulation of Telepharmacy Practice as well as for the Advisory Committee on Examinations. Mr Burgess served for five terms as the chair of the Illinois Board. He also worked as a regulatory consultant in Chicago, IL. Mr Burgess spent 40 years in a variety of roles at Walgreen Co, including national director of pharmacy operations and national director of pharmacy affairs. Mr Burgess earned his bachelor of science degree in pharmacy from the University of Tennessee and a master of business administration degree from the University of Chicago.

Executive Committee Member

Gary W. Dewhirst, RPh, DPh

Mr Dewhirst, former member of the North Dakota State Board of Pharmacy, is serving a second three-year member term, representing District 5, on the Executive Committee. As a member of NABP, Mr Dewhirst has made many contributions to the NABP District 5 meetings, including serving on the Resolutions Committee. Mr Dewhirst served two terms as the Executive Committee liaison to the Advisory Committee on Examinations. In 2014, he served as the Executive Committee liaison to the Task Force on Medication Synchronization. Mr Dewhirst was a member of the North Dakota Board from 1999 to 2018 and has served terms as the Board’s president during that time. He was owner and general manager of Hettinger Drug, LLC, in Hettinger, ND, for more than 20 years and a pharmacy manager at Thrifty White Drug for over 13 years. Mr Dewhirst earned his bachelor of science degree in pharmacy from North Dakota State University and received an honorary doctor of pharmacy license from the Oklahoma State Board of Pharmacy.

Executive Committee Member

Lenora S. Newsome, PD

Dr Newsome, President of the Arkansas State Board of Pharmacy, is serving a three-year member term, representing District 6, on the Executive Committee. As a member of NABP, Dr Newsome has served on the Task Force on Regulation of Pharmacist Care Services and the Committee on Law Enforcement/Legislation. She was also appointed as the 2018-2019 Executive Committee liaison to the Advisory Committee on Examinations. Dr Newsome previously served as president, vice president, and secretary of the Arkansas Board. In 2016, the Board received NABP’s Fred T. Mahaffey Award for their contributions to the regulation of the practice of pharmacy and their efforts to combat prescription drug abuse. Dr Newsome has been practicing pharmacy in rural communities for almost 40 years. Currently, she is the pharmacy manager at Walgreens in Camden, AR. In 2015, Dr Newsome was honored with the Percy Malone Award for Public Service by the Arkansas Pharmacists Association. Dr Newsome completed her pre-pharmacy coursework at the University of Arkansas in Fayetteville and earned her bachelor of science degree in pharmacy from the University of Arkansas for Medical Sciences College of Pharmacy in Little Rock.

Executive Committee Member

Nicole L. Chopski, PharmD, BCGP, ANP

Dr Chopski, executive director of the Idaho State Board of Pharmacy, is serving a three-year member term, representing District 7, on the Executive Committee. Dr Chopski has made many contributions to the NABP/AACP District 7 meetings and currently serves as its secretary/treasurer. She has served on many of the Association’s committees, including serving as a delegate on the Committee on Resolutions in 2016, 2014, and 2013, and as a voting delegate at the NABP Annual Meetings in 2015, 2014, and 2013. Dr Chopski was also a panelist at the NABP Interactive Member Forums in 2016 and 2012. Dr Chopski has been certified as an authorized nuclear pharmacist (ANP) by the Nuclear Regulatory Commission at Purdue University for more than a decade and was a pharmacist and partner at an independent nuclear pharmacy, Advanced Isotopes of Idaho. In addition, she was a staff pharmacist at Portneuf Medical Center and is a board certified geriatric pharmacist (BCGP) through the Board of Pharmacy Specialties. Dr Chopski earned her doctor of pharmacy degree from Idaho State University.

Executive Committee Member

Richard B. Mazzoni, RPh

Mr Mazzoni, chair of the New Mexico Board of Pharmacy, is serving a second three-year member term, representing District 8, on the Executive Committee. As a member of NABP, Mr Mazzoni served on the Association’s task forces and committees, including the the Task Force to Examine Strategies for Preventing and Reacting to Pharmacy Robberies and Thefts and the Committee on Constitution and Bylaws, as well as Executive Committee liaison for the Task Force on Expanding International Membership. Mr Mazzoni has also served as a member of the New Mexico Attorney General’s Prescription Drug Abuse Prevention Steering Committee. He is currently a consultant, and his firm, R. Mazzoni & Associates, assists clients with regulatory strategy. From 2006 to 2012, he was the director of regulatory compliance at CVS Caremark, where he was responsible for regulatory activities in 22 states and served as the company’s representative to boards of pharmacy. Mr Mazzoni earned his bachelor of science degree in pharmacy from University of the Pacific.

Candidates for the 2019-2020 Executive Committee

NABP is pleased to announce the following individuals as nominees for open officer and member positions on NABP’s 2019-2020 Executive Committee. Elections will be held in May 2019 during the 115th Annual Meeting in Minneapolis, MN. Individuals interested in qualifying as nominees for open officer or member positions should refer to NABP’s Constitution and Bylaws, Article IV, Section 3. All eligible individuals will be placed on the ballot. Check back later for more information about each candidate.

Officer Nominations

President-elect (one-year term)

Timothy D. Fensky, RPh, DPh, FACA, Massachusetts Board of Registration in Pharmacy

The current anti-regulatory environment challenges the value of state boards of pharmacy and existing laws and regulations. If elected President-elect of NABP, how would you recommend NABP assist state boards in remaining effective while eliminating unnecessary regulations?

Laws and regulations provide black and white scenarios and do not allow individuals to practice at the top of their license. Instead of the term anti-regulation, I would substitute standards of care. Standards of care are commonly accepted ideals which are prudent to one's individual practice setting, or simply stated allow individuals to make decisions to ensure the public receives safe and appropriate care. Regardless if state boards choose to regulate by regulations, standards of care or a combination of both, state boards will remain a regulating entity over the practice of pharmacy. NABP will need to dedicate resources to collaborate with stakeholders and develop standards of care which state boards can refer to when, and if, they choose to move into the anti-regulatory environment.

Curriculum Vitae (PDF)

Treasurer (one-year term)

Reginald B. “Reggie” Dilliard, DPh, Tennessee Board of Pharmacy

The volatile economic market, defined by domestic struggles and global trade wars, creates a difficult financial landscape for managing resources and investments. If elected Treasurer of NABP, what do you recommend is the best way to continue to grow NABP’s resources without raising fees?

The external factors that affect NABP’s resources must be constantly monitored. We must be diligent in our efforts to protect our core mission: to support the member boards by being flexible and open to new concepts and ideas. We must maintain tight control of our investments and protect them with a conservative strategy to provide resources needed for new ventures and ideas. It is important to have liquidity in our assets for flexibility to plan for and react to the economic and regulatory shifts in policy and licensing. As treasurer working with the EC, we would actively plan to address the ever changing economic and regulatory dynamics, explore ideas for new revenue sources, and continue to protect our current investments. This would allow NABP to grow without changing the current fees.

Curriculum Vitae (PDF)

Treasurer (one-year term)

Caroline D. Juran, RPh, DPh, Virginia Board of Pharmacy

The volatile economic market, defined by domestic struggles and global trade wars, creates a difficult financial landscape for managing resources and investments. If elected Treasurer of NABP, what do you recommend is the best way to continue to grow NABP’s resources without raising fees?

To continue to grow NABP’s resources, I would closely monitor investments, recommending adjustments as necessary to ensure growth and mitigate loss. I would recommend that NABP continue its efforts to not rely on investments to cover operational expenses, but rather to rely on strong revenue-producing programs. Such programs result from a clear vision, strong management, and close monitoring to ensure their success. NABP has provided invaluable assistance to its member boards for years and with the increasing challenges facing the boards, it is critical that NABP have sufficient resources to assist its members in protecting the public health.

Curriculum Vitae (PDF)

Member Nominations

The following candidates have been nominated for the Executive Committee member positions by their districts at the respective district meetings.

District 1 (three-year term)

Bradley S. Hamilton, RPh, Maine Board of Pharmacy

State regulators are being challenged to abandon traditional regulation and employ a “standards of care” regulatory approach. If elected a member of NABP’s Executive Committee, how would you respond to supporters of this change and how would you evaluate the feasibility of a “standards of care” regulatory strategy?

Pharmacist roles continue to develop beyond the traditional prescription delivery model. I believe standards of care may lessen the burden of overly prescriptive regulatory language which creates barriers to evolving pharmacy practice and therefore improved patient care. We must always act judiciously in protection of public health and should not regulate to simply promote advancements for the profession of pharmacy.

Evaluation should be grounded and sensible. Review different regulatory approaches being applied — nursing/medicine and share those learnings and best practices. Collaborate with state boards adopting this strategy to identify, monitor, and share outcomes with other member boards. NABP should continue to collect, share, and provide model language as this process moves forward.

Curriculum Vitae (PDF)

District 2 (three-year term)

Tejal J. Patel, MBA, PharmD, RPh, Delaware State Board of Pharmacy

State regulators are being challenged to abandon traditional regulation and employ a “standards of care” regulatory approach. If elected a member of NABP’s Executive Committee, how would you respond to supporters of this change and how would you evaluate the feasibility of a “standards of care” regulatory strategy?

"Traditional Regulation" and "Standards of Care" approaches — We need to balance between both. Change in pharmacy regulation is necessary. At the same time, regulations are required to maintain accountability. Evaluate pros and cons of current and future regulatory structure. Always keep in mind that our main role as a board member is to protect public health.

Team-based best practice approach can help evaluate the feasibility of a standard of care regulatory strategy. Work together as a team with other healthcare professionals who may already be using standard of care. While considering evolutionary change in pharmacy regulation, always determining what is best for public health and code of ethics can help during this journey of regulatory change in our Pharmacy Profession.

Curriculum Vitae (PDF)

District 2 (three-year term)

Cynthia L.W. Warriner, RPh, CDE, Virginia Board of Pharmacy

State regulators are being challenged to abandon traditional regulation and employ a “standards of care” regulatory approach. If elected a member of NABP’s Executive Committee, how would you respond to supporters of this change and how would you evaluate the feasibility of a “standards of care” regulatory strategy?

It is important to have a fair balance between standards of practice, standards of care, and regulation. Unnecessary regulations should be removed as the practice evolves, always ensuring a consistent level of public and patient safety. Listening and gathering as much information from other health care boards that may utilize standards of care models or maybe other alternative methods of insuring broadly accepted professional guidelines is important to include in discussions. Utilizing expert input and evidence-based outcomes would also provide opportunity to explore and discuss ways to incorporate a balanced approach.

Curriculum Vitae (PDF)

District 3 (one-year term)

Jeffrey J. Mesaros, PharmD, JD, RPh, Florida Board of Pharmacy

State regulators are being challenged to abandon traditional regulation and employ a “standards of care” regulatory approach. If elected a member of NABP’s Executive Committee, how would you respond to supporters of this change and how would you evaluate the feasibility of a “standards of care” regulatory strategy?

As a member of NABP’s Executive Committee, I will utilize a patient-centered focus to collaborate with supporters of a standards of care regulatory approach. Transformation beyond traditional regulation to a standards of care-based regulation must maintain safeguards for patient care while allowing pharmacy professionals to practice at the pinnacle of their education, training, and experience.

In evaluating the feasibility of this strategy, I will recommend boards: (1) determine if any of their rules can be amended to remove barriers to the delivery of pharmacist care without impacting patient safety; (2) consider NABP Task Force reports and data; and (3) leverage available information from member boards and/or other professions that have analyzed and/or implemented the strategy.

Curriculum Vitae (PDF)

District 5 (three-year term)

Diane M. Halvorson, RPhTech, CPhT, North Dakota State Board of Pharmacy

State regulators are being challenged to abandon traditional regulation and employ a “standards of care” regulatory approach. If elected a member of NABP’s Executive Committee, how would you respond to supporters of this change and how would you evaluate the feasibility of a “standards of care” regulatory strategy?

Serving as an Executive Committee Member, I will be open to any information from the supporters who are bringing the question forward. Then, I would submit the information to the Executive Committee to discuss. Additionally, I would research if any states have adopted this model as well as if any other healthcare professionals have a similar model. An important message that I want to point out, if elected as an Executive Committee Member, I identify there is a process to follow in responding to these types of questions. It will be my responsibility to utilize the resources available to me to gather information and work as a team on the Executive Committee to provide the best leadership to the members of NABP sharing the common goal of patient safety.

Curriculum Vitae (PDF)

District 5 (three-year term)

Shane R. Wendel, PharmD, RPh, North Dakota State Board of Pharmacy

State regulators are being challenged to abandon traditional regulation and employ a “standards of care” regulatory approach. If elected a member of NABP’s Executive Committee, how would you respond to supporters of this change and how would you evaluate the feasibility of a “standards of care” regulatory strategy?

NABP serves as a catalyst to all State Boards of Pharmacy. Regulation approaches are ever changing and NABP will continue to assist Boards of Pharmacy with this pendulum swing of traditional regulation to “standards of care” approach. One of NABP’s main values is to create platforms of information sharing so lessons can be learned before learning the hard way. The NABP Model Act is a great resource for states to use. NABP’s job is to assist states with change not decide it for them. My personal opinion is the “standards of care” model works well in parts of regulation but is not a cover-all. This approach of regulation will continue to evolve with time, and NABP will be in the center of it all, helping us regulate and protect the public we are sworn to serve.

Curriculum Vitae (PDF)